Ken Griffin Boston Scientific Corp Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Boston Scientific Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 1,216,800 shares of BSX stock, worth $125 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,216,800
Previous 644,400
88.83%
Holding current value
$125 Million
Previous $57.6 Million
113.27%
% of portfolio
0.02%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding BSX
# of Institutions
1,880Shares Held
1.22BCall Options Held
9.46MPut Options Held
7.03M-
Vanguard Group Inc Valley Forge, PA137MShares$14.1 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA64.5MShares$6.62 Billion0.28% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.56 Billion3.04% of portfolio
-
Wellington Management Group LLP Boston, MA33.2MShares$3.41 Billion0.67% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...